TRHC TABULA RASA HEALTHCARE

American Academy of Home Care Medicine Partners with Tabula Rasa HealthCare to Offer Online Clinical Documentation Education for Members

American Academy of Home Care Medicine Partners with Tabula Rasa HealthCare to Offer Online Clinical Documentation Education for Members

MOORESTOWN, N.J., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced a partnership between TRHC’s Capstone Performance Systems service line and the . As part of the partnership agreement, AAHCM will offer the newest program product from Capstone, , to AAHCM members at a discounted rate, and Capstone will participate in AAHCM’s Industry Relations Council (IRC).

“We are delighted to welcome Capstone to the IRC,” said Brent Feorene, Executive Director of AAHCM. “Capstone’s participation in the IRC furthers the Academy’s long-standing commitment to creating partnerships that ensure members have access to best-in-class tools, information, and the support they need.”

The CDE Online Education program provides expert training in clinical documentation for compliance and revenue optimization with the convenience of 24/7 access. More than ten hours of focused content such as risk adjustment methodology, the provider’s role in risk adjustment, and documenting specific conditions is included.

“We are excited to offer this new online education that instructs providers in accurate and concise documentation, an important component in risk-based contracting from both a compliance and revenue perspective,” stated George W. Brett, MD, Capstone’s Senior Vice President for Consulting Services and Chief Medical Officer.

The CDE Online Education curriculum was developed by risk adjustment experts for physicians and other clinicians who provide care in value-based settings, including Programs of All-inclusive Care for the Elderly (PACE), Medicare Advantage, Managed Medicare, and Accountable Care Organizations.

Capstone is a service of TRHC’s CareVention HealthCare division.

About Tabula Rasa HealthCare

Tabula Rasa HealthCare (TRHC) provides medication safety solutions empowering healthcare professionals to optimize medication regimens and reduce medication-related risk, specifically targeting adverse drug events. Utilizing its proprietary medication decision science technology, MedWise™, TRHC improves patient outcomes, reduces hospitalizations, and lowers healthcare costs. Additionally, TRHC provides an extensive clinical telepharmacy network across the U.S. Our solutions are trusted by health plans and pharmacies nationwide to help drive value-based payment results. For more information, visit .

About CareVention HealthCare

CareVention HealthCare offers comprehensive, integrated solutions and services for value-based care organizations, including for every stage of Programs of All-inclusive Care for the Elderly (PACE), from PACE exploration at the state and organizational levels through start-up and ongoing operations. Integrated end-to-end services assure regulatory compliance, participant health and safety, efficient workflows, and optimized financial management. For more information, visit .

About Capstone Performance Systems

Capstone Performance Systems, a CareVention HealthCare company, provides clinical documentation training and Medicare risk adjustment services to value-based care organizations. Services including auditing and concurrent coding ensure compliance and optimal reimbursement. For more information, visit .

Forward-Looking Statements

This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Mitigation technology. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 2, 2020, and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website ir.trhc.com or upon request from our Investor Relations Department. Any forward-looking statement speaks only as of the date on which it was made. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.

TRHC Media Contact

Dianne Semingson



T: (215) 870-0829

TRHC Investor Contact

Frank Sparacino



T: (866) 648-2767



EN
24/11/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on TABULA RASA HEALTHCARE

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Daily Ratings Report: July 27, 2022

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Daily Ratings Report: July 25, 2022

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Tabula Rasa Healthcare Inc: 3 directors

A director at Tabula Rasa Healthcare Inc bought 2,000 shares at 5.630USD and the significance rating of the trade was 34/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch